Charles River Labs Intl buy The Goldman Sachs Group, Inc.
Start price
23.01.25
/
50%
€159.40
Target price
23.01.26
€182.70
Performance (%)
15.50%
End price
24.01.26
€184.10
Summary
This prediction ended on 24.01.26 with a price of €184.10. The prediction had a final performance of 15.50%. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Charles River Labs Intl | 2.632% | 2.632% | 63.633% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $220.00 to $190.00. They now have a "buy" rating on the stock.
Ratings data for CRL provided by MarketBeat
In the thread Trading Charles River Labs Intl
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Stopped prediction by The_Goldman_Sachs_Gr for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€199.65
06.06.24
06.06.24
€266.42
06.06.25
06.06.25
-36.41%
07.06.25
07.06.25
